Literature DB >> 3067416

Proposed mechanisms of action in thalidomide embryopathy.

T D Stephens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3067416     DOI： 10.1002/tera.1420380307

Source DB:  PubMed          Journal:  Teratology        ISSN： 0040-3709


× No keyword cloud information.
  16 in total

1.  Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.

Authors:  H Sauer; J Günther; J Hescheler; M Wartenberg
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Teratogenic effects of thalidomide: molecular mechanisms.

Authors:  Takumi Ito; Hideki Ando; Hiroshi Handa
Journal:  Cell Mol Life Sci       Date:  2011-01-05       Impact factor: 9.261

Review 3.  The Redox Theory of Development.

Authors:  Jason M Hansen; Dean P Jones; Craig Harris
Journal:  Antioxid Redox Signal       Date:  2020-04-01       Impact factor: 8.401

4.  In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice.

Authors:  Hiroshi Yamazaki; Hiroshi Suemizu; Sho Igaya; Makiko Shimizu; Norio Shibata; Masato Nakamura; Goutam Chowdhury; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2011-02-07       Impact factor: 3.739

Review 5.  Thalidomide-type teratogenicity: structure-activity relationships for congeners.

Authors:  R L Smith; S C Mitchell
Journal:  Toxicol Res (Camb)       Date:  2018-09-26       Impact factor: 3.524

Review 6.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

Review 7.  Thalidomide: rationale for renewed use in immunological disorders.

Authors:  U Schuler; G Ehninger
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

8.  Thalidomide is an inhibitor of angiogenesis.

Authors:  R J D'Amato; M S Loughnan; E Flynn; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 9.  Thalidomide-induced teratogenesis: history and mechanisms.

Authors:  Neil Vargesson
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-04

10.  Maternal factors, medications, and drug exposure in congenital limb reduction defects.

Authors:  U G Froster; P A Baird
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.